Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 112 for “"Inflammation and Cancer"”.
-
Targeting Nrf2 in Inflammation and Cancer
… proteins. Activation of Nrf2 protects against inflammation and oxidative damage in disease models in vitro and in vivo. Nrf2 activation may be a good therapeutic strategy in these diseases. Some dietary components activate Nrf2, which may be partially responsible for their beneficial effects in …
-
Annexin-A1 signalling in inflammation and cancer
… contrasting data available. A role for ANXA1 and the formyl peptide receptors (FPRs) through which it signals has been suggested in a range of inflammatory diseases and cancers. This thesis aimed to investigate the ANXA1-FPR signalling axis in two primary examples of these disease settings in …
-
The role of TPL2 kinase in inflammation and cancer
Several clinical and epidemiological studies have provided evidence supporting that hepatic inflammation and tissue damage is the critical cause of liver disease directing the development of liver cirrhosis and hepatocellular carcinoma (HCC). Hence, liver disease corresponds to a major healthcare …
-
The Effects of Vitamin B6 and B12 on Inflammation and Cancer
We are only just beginning to understand the intricate relationship between nutrition, immune health, inflammation, and cancer. Epidemiological studies have demonstrated a clear association between inflammation and cancer development. Both undernutrition and overnutrition (malnutrition) have been …
-
Glutaminase Modulates T Cell Metabolism and Function in Inflammation and Cancer
… immune response, helper T cells must proliferate and upregulate key metabolic programs including glucose and glutamine uptake. Metabolic reprogramming is imperative for appropriate T cell responses, as inhibition of glucose or glutamine uptake hinders T cell effector responses. Glutamine and …
-
Investigating the role of CXCR2 signalling in pancreatic inflammation and cancer
… bone marrow derived suppressor cells (BMDCs) and once differentiated neutrophils.
-
Characterisation of the role of Fas in intestinal inflammation and cancer
Background: The role of Fas (CD95) and its ligand, Fas ligand (FasL/CD95L), is poorly understood in the intestine. Whilst Fas is best studies in terms of its function in apoptosis, recent studies suggest that Fas ligation may mediate additional, non-apoptotic functions such as inflammation. Toll …
-
Biological and immunological activities of probiotic microorganisms in models of inflammation and cancer
… track, such as inflammatory bowel disease and colorectal cancer, are a substantial health hazard with high incidence and fatality rate. There is an association between the two, since patients suffering from inflammatory bowel disease have a higher risk of developing cancer, arising from …
-
Immunity, Inflammation and Cancer: The role of Foxp3, TLR7 and TLR8 in gastrointestinal cancer
… benefit of the tumor. For gastrointestinal cancers, in particular pancreatic and colorectal cancer (CRC), the clinical relevance of Foxp3 is not clear to date. Therefore the aim of this study was to analyze its impact in CRC and pancreatic cancer. To determine the relevance of Foxp3 for …
-
The Differential Roles of pH sensing G-Protein Coupled Receptors in Inflammation and Cancer
Intestinal inflammation is a burdening disease that may occur due to an aberrative immune response to certain drugs, infections, genetics, or unknown environmental factors. Inflammatory bowel disease (IBD) is of special concern as long-standing chronic intestinal inflammation may increase the risk …
-
The development and application of activity-based sensing probes to monitor inflammation and cancer aggression
Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2025-05-01
-
Exploring and exploiting the molecular function of endosialin (CD248): a clinical biomarker in inflammation and cancer
… receptor that has shown to play a role in both cancer and inflammation. Little is known about CD248’s structure, function and mechanism of action. Deletion mutants of CD248 were generated by overlapping fusion PCR, which were then stably-transfected into MG63 cells, detected by …
-
Do Finances Determine Our Fate?: Understanding the Relationships Between Socioeconomic Status, Inflammation, and Cancer Recurrence Risk
… status (SES) are more likely to experience a cancer recurrence relative to individuals with a higher SES. This may be partially explained by the stressors of living with a low SES. These stressors can increase inflammatory markers known to elevate the risk of cancer development. …
-
Exploring the potential of novel Pellino2-targeted compounds to control pathways and cells that drive inflammation and cancer
… valuable therapeutic agents in the treatment of inflammation and cancer. However, there is still a need to identify additional molecular targets amenable to therapeutic exploitation. Pellino proteins form a three-membered family of E3 ubiquitin ligases, and an understanding of their crucial roles …
-
Effects of β₂-Adrenergic Receptor Signaling Pathways on Adaptive T Cell Responses, Implications for Inflammation and Cancer Immunity
… on immune function. Adaptive immunity detects and responds to new pathogens and cancerous cells. T cells are key regulators of this system, coordinating immune responses and maintaining long-term memory. They express β₂-adrenergic receptors (β₂-AR), which respond to stress hormones like …
-
Investigating the role of the chitinase-like proteins in chronic inflammation and cancer induced by the Epstein-Barr virus oncogene LMP1
Abstract not currently available.
-
Inflammation and Cancer: Modelling the consequences of radiotherapy- and Hmgb1-induced inflammation on early-stage skin cancer progression in zebrafish larvae
Alongside tumour resection, cancer radiotherapy is a gold standard intervention to manage cancer progression and is given to 27% of cancer patients in a curative or palliative capacity as part of their treatment in England each year (NCRAS, 2017). Yet, by virtue of killing cancer cells, …
Page 1 of 6